Patent Assignment
Reel/Frame 073032/0390
Change of Address
Recorded: 2025-10-08
Pages: 7
Assignor
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Executed: 2024-01-02
Assignee
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
GSK MEDICINES RESEARCH CENTRE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2NY, UNITED KINGDOM
Covered Properties
(158)
Heterocyclic Amides Useful as Protein Modulators
Nozzle for a Nasal Inhaler
Heterocyclic Amides as Kinase Inhibitors
Sanfetrinem or a Salt or Ester Thereof for Use in Treating Mycobacterial Infection
Icos Binding Proteins
Compounds
Heterocyclic Amides Useful as Protein Modulators
Patent:
10,981,901 →
Application:
16/091,189 →
Substituted Pyridines as Inhibitors of DNMT1
Actuation Counter
Novel Processes for the Production of Oligonucleotides
Icos Binding Proteins
Compounds
Icos Binding Proteins
Buffer System for Protein Purification
Heterocyclic Amides as Kinase Inhibitors
Novel Soluble Guanylate Cyclase Activators and Their Use
Heterocyclic Amides as Kinase Inhibitors
METHODS FOR TREATING NEISSERIA GONORRHOEAE INFECTION WITH 2-({4-[(3,4-DIHYDRO-2H-PYRANO[2,3-c]PYRIDIN-6-YLMETHYL)AMINO]-1-PIPERIDINYL}METHYL)-1,2-DIHYDRO-3H,8H-2a,5,8a-TRIAZAACENAPHTHYLENE-3,8-DIONE
Heterocyclic Amides Useful as Protein Modulators
Carboxyesterase Biocatalysts
Oxepinopyrazole Derivatives as Inhibitors of P13-Kinase Activity
Compounds Useful in HIV Therapy
Method for Treating Gonorrhea with (2R)-2-({4-[(3,4-Dihydro-2H-Pyrano[2,3-C]Pyridin-6-Ylmethyl)Amino]-1-Piperidinyl}Methyl)-1,2-Dihydro-3H,8H-2A,5,8A-Triazaacenaphthylene-3,8-Dione
Novel Compounds for the Treatment of Parasitic Infections
Chemical Compounds
Novel Compounds
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS PI4K INHIBITORS
Methods for Purifying Antibodies
Antibodies with Reduced Binding to Process Impurities
Heterocyclic Amides as Kinase Inhibitors
Ingenol Analogs, Pharmaceutical Compositions and Methods of Use Thereof
Compounds
Method of Producing a Recombinant Protein
Antituberculosis Agent
Chemical Compounds
Biopharmaceutical Compositions Comprising Antibody Variants
Biopharmaceutical Compositions and Related Methods
Combination Treatment for Cancer with Anti-Bcma Binding Protein and Proteosome Inhibitor
Heterocyclic Amides as Kinase Inhibitors
Novel Processes for the Production of Oligonucleotides
Immunogenic Composition, Use and Method of Treatment
Novel Compounds
Heterocyclic Amides as Kinase Inhibitors
Biopharmaceutical Compositions Comprising Nucleic Acids Encoding Il-5 Binding Proteins
Novel Tetrazole Compounds and Their Use in the Treatment of Tuberculosis
C-Mannoside Compounds Useful for the Treatment of Urinary Tract Infections
Novel Soluble Guanylate Cyclase Activators and Their Use
Antibody Variants
Fluticasone Furoate in the Treatment of Copd
Application:
17/205,466 →
Publication:
US 2021/0205331
Novel Processes for the Production of Oligonucleotides
Antibody Variants
Modular Aseptic Production System
Chemical Compounds
Compounds
Heterocyclic Amides as Kinase Inhibitors
Compounds Useful in HIV Therapy
Methods of Preparing Stable Liquid Therapeutic Protein Compositions
Application:
17/270,746 →
Publication:
US 2021/0187107
Lid/Tray Package for an Inhalation Device
Patent:
679,586 →
Application:
29/426,021 →
Hydroxamic Acid Derivatives as Inhibitors of Hdac Enzymatic Activity
Buffer System for Protein Purification
Tray Package For an Inhalation Device
Patent:
754,533 →
Application:
29/485,918 →
Antigen Binding Proteins
Hydroxamates as Inhibitors of Histone Deacetylase
Peptide Yy Analogs
Aggregate Particles
Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
Heterocyclic Amides as Kinase Inhibitors
Anti-Lag-3 Binding Proteins
Icos Binding Proteins
Fluticasone Furoate in the Treatment of Copd
Novel Compounds
Compounds
Novel Heteroaryl Substituted Compounds as Ror Gamma Inhibitors
C-Mannoside Compounds Useful for the Treatment of Urinary Tract Infections
Compounds Useful in HIV Therapy
Hepatitis B Immunisation Regimen and Compositions
Application:
17/436,183 →
Publication:
US 2022/0339281
Non Peptidic Heterobivalent Molecules for Treating Inflammatory Diseases
Application:
17/412,070 →
Publication:
US 2021/0379044
Process for the Purification of Recombinant Polypeptides
Application:
17/600,276 →
Publication:
US 2022/0177517
MRGX2 Antagonists
Novel Compounds
Gepotidacin for Use in the Treatment of Bacterial Urinary Tract Infections
Application:
17/600,660 →
Publication:
US 2022/0184071
Substituted Biphenyl or Phenylheteroaryl-Mannosides as Antagonists of Fimh
IL-7 Binding Proteins and Their use in Medical Therapy
Immunogenic Composition, Use and Method of Treatment
Application:
17/499,004 →
Publication:
US 2022/0023409
5,6,7,7a-Tetrahydrocyclopenta[f]pyrido[1,2-h][1,7]naphthyridin-11(4bH)-one Compounds and Methods of Use
2,3-Dihydroquinazolin Compounds as NAV1.8 Inhibitors
Application:
17/617,479 →
Publication:
US 2023/0103791
Antigen Binding Proteins
Combination for the Treatment of Infections Caused by Mycoplasma Genitalium
Application:
17/619,367 →
Publication:
US 2022/0257615
Reducing Malaria Transmission
Application:
17/621,434 →
Publication:
US 2023/0051209
Biopharmaceutical Compositions and Related Methods
Application:
17/633,115 →
Publication:
US 2022/0289859
CR2 Binding Proteins and their use in Medical Therapy
Application:
17/639,096 →
Publication:
US 2023/0032643
Method of Predicting Production Stability of Clonal Cell Lines
Application:
17/763,998 →
Publication:
US 2022/0344000
Heterocyclic Amides Useful as Protein Modulators
Treatment for Primary Amyloidosis with Anti-Bcma Binding Protein
Method for Detecting Polysorbates
Application:
17/912,223 →
Publication:
US 2023/0184750
Cathepsin Inhibitors for Preventing or Treating Viral Infections
Application:
17/913,870 →
Publication:
US 2024/0066037
Antigen Binding Proteins
Substituted Pyridines as DNMT1 Inhibitors
Modular Aseptic Production System
Combination Treatment for Cancer Involving Anti-Icos and Anti-PD1 Antibodies, Optionally Further Involving Anti-TIM3 Antibodies
Application:
17/911,937 →
Publication:
US 2023/0140694
Combination Treatment for Cancer
Application:
17/911,816 →
Publication:
US 2023/0131598
PI4KIIIBETA Inhibitors
Application:
17/941,838 →
Publication:
US 2023/0124394
Display Screen with Graphical User Interface
Patent:
1,053,891 →
Application:
29/852,639 →
Chimeric Antigen Receptors Targeting Claudin-3 and Methods for Treating Cancer
Application:
17/950,667 →
Publication:
US 2023/0192842
Crystalline Forms of Gepotidacin
Carboxyesterase Biocatalysts
Methods for Purifying Antibodies
Application:
17/978,791 →
Publication:
US 2023/0046182
Antigen Binding Protein
Application:
18/006,924 →
Publication:
US 2023/0279089
Antigen Binding Proteins
Application:
18/095,854 →
Publication:
US 2023/0242642
Antigen Binding Proteins
Application:
18/098,792 →
Publication:
US 2023/0295295
Interleukin 5 Binding Protein Dosage Regimen
Application:
18/258,588 →
Publication:
US 2024/0043524
Chemical Compounds
Application:
18/330,569 →
Publication:
US 2023/0416287
Chemical Compounds Useful for Inhibiting Nav1.8 Voltage-Gated Sodium Channels and Treating Nav1.8 Mediated Diseases
Application:
18/256,989 →
Publication:
US 2025/0084112
Nitrogen Containing 2,3-Dihydroquinazolinone Compounds as Nav1.8 Inhibitors
Application:
18/256,982 →
Publication:
US 2024/0083896
C-Mannoside Compounds Useful for the Treatment of Urinary Tract Infections
Substituted Pyridines as DNMT1 Inhibitors
Oral Solid Dose Formulations
Application:
18/262,938 →
Publication:
US 2024/0366511
Antigen Binding Proteins and Combinations Thereof
Application:
18/552,477 →
Publication:
US 2024/0166747
Anti-BCMA Antibody Drug Conjugate Combination Treatment for Cancer
IL-7 Binding Proteins and Their Use in Medical Therapy
Combination Therapies for Treating Cancer
Application:
18/562,868 →
Publication:
US 2025/0263495
Methods for Treating Infections Caused by Neisseria gonorrhoeae
Application:
18/509,964 →
Publication:
US 2024/0108620
High-Throughput Assay for Cell Migration, Chemotaxis, and Function
Pharmaceutical Compound
Application:
18/569,648 →
Publication:
US 2024/0317774
Combination Therapies for Treating Cancer
Application:
18/697,515 →
Biopharmaceutical Compositions and Stable Isotope Labeling Peptide Mapping Method
Application:
18/291,272 →
Publication:
US 2024/0369568
Triazole-Substituted Imidazo[1,2-a]Pyrimidines as Cgas Inhibitors
Interleukin 5 Binding Protein Dosage Regimen for Use in Treating Polyangiitis, Hypereosinophilic Syndrome, Chronic Rhinosinusitis with Nasal Polyps (Crswnp), or Chronic Rhinosinusitis Without Nasal Polyps (Crssnp)
Application:
18/715,320 →
Publication:
US 2025/0042985
Methods of Treating an Il-5 Mediated Disease by Administering an Il-5 Binding Protein
Application:
18/613,481 →
Publication:
US 2024/0417456
Crispr/CAS9-Based Fusion Proteins for Modulating Gene Expression and Methods of Use
Application:
18/698,042 →
Publication:
US 2025/0236854
Combination Therapy for Cancer
Application:
18/730,820 →
Compounds
Application:
18/646,178 →
Publication:
US 2024/0300965
Pyrazine Compounds Useful in the Treatment of Parasitic Protozoal Infection
Application:
18/711,209 →
Publication:
US 2025/0122167
Gepotidacin and Vancomycin for Use in the Treatment of an Infection Caused by Staphylococcus Saprophyticus
Application:
18/728,991 →
Publication:
US 2025/0099535
Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
Application:
18/667,078 →
Publication:
US 2024/0317729
Combination Therapy for Treating Hepatitis B Virus Infections
Application:
18/832,756 →
Publication:
US 2025/0092401
Method of Treating Chronic Hepatitis B
Application:
18/851,303 →
Publication:
US 2025/0215431
Antigen Binding Proteins
Application:
63/651,067 →
2,4-Dioxotetrahydropyrimidinyl Deratives as Degrons in Protacs
Application:
18/849,815 →
Publication:
US 2025/0205344
PI4KIIIBETA Inhibitors
Application:
18/739,860 →
Publication:
US 2024/0336618
Antigen Binding Proteins
Application:
63/662,557 →
Compounds
Application:
18/839,839 →
Publication:
US 2025/0129084
Novel Processes for the Production of Polynucleotides Including Oligonucleotides
Application:
18/853,613 →
Publication:
US 2025/0223620
IL-7 Binding Proteins and Their Use in Medical Therapy
Application:
18/823,000 →
Publication:
US 2024/0425581
Cytotoxicity Targeting Chimeras
Application:
18/682,193 →
Publication:
US 2025/0136722
Cytotoxicity Targeting Chimeras for CCR2-Expressing Cells
Cytotoxicity Targeting Chimeras for C-C Chemokine Receptor 2-Expressing Cells
Application:
18/800,888 →
Publication:
US 2025/0154288
Cytotoxicity Targeting Chimeras for CCR2-Expressing Cells
Application:
18/802,386 →
Publication:
US 2025/0057958
Cytotoxicity Targeting Chimeras for CXCR3-Expressing Cells
Application:
18/802,915 →
Publication:
US 2025/0051479
Cytotoxicity Targeting Chimeras for Prostate Specific Membrane Antigen-Expressing Cells
Application:
18/808,401 →
Publication:
US 2025/0057827
Cytotoxicity Targeting Chimeras for Folate Receptor-Expressing Cells
Application:
18/808,367 →
Publication:
US 2025/0049932
Cytotoxicity Targeting Chimeras for Fibroblast Activation Protein-Expressing Cells
Application:
18/812,114 →
Publication:
US 2025/0064947
Nitrogen Containing Condensed 2,3-Dihydroquinazolinone Compounds as NAV1.8 Inhibitors
Application:
18/872,308 →
Compositions and Methods for Producing Smooth Muscle Cells
Application:
18/932,004 →
Publication:
US 2025/0145959
Compositions and Methods for Producing Primordial Germ Cell-Like Cells
Application:
18/930,210 →
Publication:
US 2025/0136933
5,6,7,7a-Tetrahydrocyclopenta[f]pyrido[1,2-h][1,7] naphthyridin-11(4bH)-one Compounds and Methods of use Use (as amended)
Application:
18/943,115 →
Publication:
US 2025/0066361
Triazole-Substituted Imidazo[1,2-a]Pyrimidines as Cgas Inhibitors
Application:
18/966,276 →
Publication:
US 2025/0092053
Anti-BCMA Antibody Drug Conjugate Combination Treatment for Cancer
Application:
18/985,239 →
Publication:
US 2025/0122297
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 6, 2022
From: CHARNLEY, ADAM K.; DONG, XIAOYANG; DODSON, JASON W.; RAMANJULU, JOSHI M.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 060105/0468 →
Assignment of Assignor's Interest
Jun 22, 2022
From: KHANDEKAR, SANJAY; MAYES, PATRICK; OPALINSKA, JOANNA
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 060279/0749 →
Assignment of Assignor's Interest
Aug 26, 2022
From: SANMARTIN, FRANCESCO
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 060913/0224 →
Assignment of Assignor's Interest
Sep 20, 2022
From: BARTON, NICHOLAS PAUL; BERTRAND, SOPHIE MARIE; DOWN, KENNETH; GRAY, MATTHEW
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 061488/0950 →
Assignment of Assignor's Interest
Sep 20, 2022
From: BALLAS, MARC S.; ELLIS, CATHERINE E.; HIRSCHFELD, STEVEN
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 061158/0224 →
Assignment of Assignor's Interest
Sep 20, 2022
From: BALLAS, MARC S.; ELLIS, CATHERINE E.; HIRSCHFELD, STEVEN
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 061158/0069 →
Assignment of Assignor's Interest
Sep 23, 2022
From: BAVARI, SINA
To: THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY
Reel/Frame 061190/0931 →
Assignment of Assignor's Interest
Sep 23, 2022
From: KANE, CHRISTOPHER; SOLOVEVA, VERONICA
To: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Reel/Frame 061190/0682 →
Assignment of Assignor's Interest
Sep 23, 2022
From: PEAT, ANDREW JAMES
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 061190/0820 →
Assignment of Assignor's Interest
Oct 14, 2022
From: KISHORE, KAUSHAL; TALEKAR, MALA K.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 061420/0943 →
Assignment of Assignor's Interest
Oct 20, 2022
From: DEGENHARDT, YAN Y.; GUAN, JUN; HANCE, KENNETH WILLIAM; MORLEY, PETER JOSEPH
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 061482/0057 →
Assignment of Assignor's Interest
Jan 12, 2023
From: HAMBLIN, PAUL ANDREW; LEWIS, ALAN PETER; WEBB, THOMAS MATTHEW
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 062362/0274 →
Assignment of Assignor's Interest
Jan 19, 2023
From: HAMBLIN, PAUL ANDREW; LEWIS, ALAN PETER; WEBB, THOMAS MATTHEW
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 062420/0072 →
Assignment of Assignor's Interest
Feb 27, 2023
From: CARNES, KATIE A.; SHEARER, JUSTIN W.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 062815/0709 →
Assignment of Assignor's Interest
Apr 19, 2023
From: COUCH, RICKY WAYNE; DAI, WENNING; DAVISON, SENTHIL; PENDRAK, ISRAIL
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 063363/0426 →
Assignment of Assignor's Interest
May 2, 2023
From: BENOWITZ, ANDREW B.; KING, BRYAN WAYNE; ROMERIL, STUART PAUL; FOSBENNER, DAVID T
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 063504/0658 →
Assignment of Assignor's Interest
Jun 28, 2023
From: CLARKSON, JANE E.; DIMECH, CAROLINE J.; HARRIS, CAROL A.; ZHANG, JIAN G.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 064095/0818 →
Assignment of Assignor's Interest
Jul 24, 2023
From: DONG, XIAOYANG; ELBAN, MARK ANDREW; GUANG, JIE; HO, MING-HSUN
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 064358/0182 →
Assignment of Assignor's Interest
Aug 25, 2023
From: SPLETSTOSER, JARED TROY; MATTHEWS, JAY M.; PRICE, ALAN T.; GUANG, JIE
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 064702/0934 →
Assignment of Assignor's Interest
Oct 29, 2024
From: GOKLEN, KENT E.; MOLEK, JESSICA RACHEL; DUMETZ, ANDRE; LEVY, NICHOLAS E.
To: GLAXOSMITHKLINE LLC
Reel/Frame 069050/0736 →
Assignment of Assignor's Interest
Oct 29, 2024
From: GLAXOSMITHKLINE LLC
To: GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
Reel/Frame 069050/0809 →
Assignment of Assignor's Interest
Oct 29, 2024
From: GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 069050/0885 →
Assignment of Assignor's Interest
Feb 19, 2025
From: BROWN, KRISTIN K.; DORR, BRENT M.; FUERST, DOUGLAS E.; HONICKER, KATHERINE JOYCE
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 070261/0646 →
Assignment of Assignor's Interest
Feb 19, 2025
From: VOLADRI, RAMA
To: CODEXIS, INC.
Reel/Frame 070261/0869 →
Assignment of Assignor's Interest
Feb 19, 2025
From: CODEXIS, LTD.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 070262/0036 →